DuPont price target lowered to $75 from $85 at Wells Fargo

Wells Fargo lowered the firm’s price target on DuPont to $75 from $85 and keeps an Overweight rating on the shares. The firm remains bullish on DuPont thanks to its strong balance sheet, stability in W&P, exposure to a recovery in China, and attractive valuation, with further upside from the acquisition of a high-quality healthcare name.